ArticleJournal of pancreatic cancer2019

A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Anteneh A Tesfaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.